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microRNA-449a acts as a master regulator of the brain tumour phenotype  
 
Introduction: Combinations of genetic mutations in tumour initiating cells determine the 
phenotype of brain tumours. In our experimental model, deletion of both Pten and p53 genes in 
the stem cells of murine subventricular zone (SVZ) gave rise to glial phenotype tumours, 
whereas deletion of Rb and p53 generated predominantly primitive neuroectodermal tumours 
(PNET’s) (1, 2). This suggests that a switch may exist that directs differentiation to glial or 
neural lineage and may depend on individual oncogenic signals. Here we aimed at identifying 
the role of microRNAs, strong post-transcriptional regulators, in determining the phenotypic 
characteristics of the brain tumour.   
Material and methods: MicroRNA arrays were performed on solid brain tumours. Subsequent 
validation experiments were done with Neural stem cells cultures from p53lox/lox; Ptenlox/lox or 
p53lox/lox; Rblox/lox mice, recombined in vitro with adeno-cre. Allografts were generated by grafting 
the stem cells into to the brain of nude mice.  
Results: We found that microRNA-449a is upregulated in experimental PNETs (tumours from 
Rb/p53 grafted cells) and in vitro recombined cells with the same mutations. Inhibition of 
microRNA-449a in Rb/p53 deficient cells increased invasiveness, proliferation and self-renewal. 
The mice with tumours generated from miR-449a inhibitor treated Rb/p53 cells showed shorter 
survival and a phenotypic switch from PNET to glioma. The downstream targets of microRNA-
449a revealed multiple signalling molecules involved in neurogenesis. The results were 
confirmed in human brain tumour tissues with PNET components.  
Conclusions: Our study demonstrates that microRNA-449a is important in inhibiting growth and 
invasion of brain tumour-initiating cells and is a key regulator in sustaining PNET like phenotype 
of the brain tumour. The role of the downstream targets of this microRNA have been identified 
and are being validated. 
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